Toward a reduction of the global burden of cervical cancer

Thomas E. Rohan, Robert D. Burk, Eduardo L. Franco

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Of the 190,000 deaths from cervical cancer that occur annually worldwide, the majority take place in developing countries. Recent advances in our understanding of the causes and natural history of cervical neoplasia and, in particular, the establishment of the central role of human papilloma virus (HPV) infection have created opportunities for the primary and secondary prevention of cervical cancer. In the future, prevention efforts will include the incorporation of HPV testing as an adjunct to or replacement for cytology-based screening programs and the use of recombinant DNA technologies for the development of prophylactic vaccines.

Original languageEnglish (US)
JournalAmerican Journal of Obstetrics and Gynecology
Volume189
Issue number4 SUPPL.
DOIs
StatePublished - Oct 2003

Fingerprint

Papillomaviridae
Uterine Cervical Neoplasms
Recombinant DNA
Virus Diseases
Primary Prevention
Secondary Prevention
Developing Countries
Cell Biology
Vaccines
Technology
Neoplasms

Keywords

  • Cervical cancer
  • Human papilloma viruses
  • Prevention
  • Screening
  • Vaccination

ASJC Scopus subject areas

  • Medicine(all)
  • Obstetrics and Gynecology

Cite this

Toward a reduction of the global burden of cervical cancer. / Rohan, Thomas E.; Burk, Robert D.; Franco, Eduardo L.

In: American Journal of Obstetrics and Gynecology, Vol. 189, No. 4 SUPPL., 10.2003.

Research output: Contribution to journalArticle

@article{1232618703e041478b70e43c1fd858f7,
title = "Toward a reduction of the global burden of cervical cancer",
abstract = "Of the 190,000 deaths from cervical cancer that occur annually worldwide, the majority take place in developing countries. Recent advances in our understanding of the causes and natural history of cervical neoplasia and, in particular, the establishment of the central role of human papilloma virus (HPV) infection have created opportunities for the primary and secondary prevention of cervical cancer. In the future, prevention efforts will include the incorporation of HPV testing as an adjunct to or replacement for cytology-based screening programs and the use of recombinant DNA technologies for the development of prophylactic vaccines.",
keywords = "Cervical cancer, Human papilloma viruses, Prevention, Screening, Vaccination",
author = "Rohan, {Thomas E.} and Burk, {Robert D.} and Franco, {Eduardo L.}",
year = "2003",
month = "10",
doi = "10.1067/S0002-9378(03)01079-2",
language = "English (US)",
volume = "189",
journal = "American Journal of Obstetrics and Gynecology",
issn = "0002-9378",
publisher = "Mosby Inc.",
number = "4 SUPPL.",

}

TY - JOUR

T1 - Toward a reduction of the global burden of cervical cancer

AU - Rohan, Thomas E.

AU - Burk, Robert D.

AU - Franco, Eduardo L.

PY - 2003/10

Y1 - 2003/10

N2 - Of the 190,000 deaths from cervical cancer that occur annually worldwide, the majority take place in developing countries. Recent advances in our understanding of the causes and natural history of cervical neoplasia and, in particular, the establishment of the central role of human papilloma virus (HPV) infection have created opportunities for the primary and secondary prevention of cervical cancer. In the future, prevention efforts will include the incorporation of HPV testing as an adjunct to or replacement for cytology-based screening programs and the use of recombinant DNA technologies for the development of prophylactic vaccines.

AB - Of the 190,000 deaths from cervical cancer that occur annually worldwide, the majority take place in developing countries. Recent advances in our understanding of the causes and natural history of cervical neoplasia and, in particular, the establishment of the central role of human papilloma virus (HPV) infection have created opportunities for the primary and secondary prevention of cervical cancer. In the future, prevention efforts will include the incorporation of HPV testing as an adjunct to or replacement for cytology-based screening programs and the use of recombinant DNA technologies for the development of prophylactic vaccines.

KW - Cervical cancer

KW - Human papilloma viruses

KW - Prevention

KW - Screening

KW - Vaccination

UR - http://www.scopus.com/inward/record.url?scp=0242475322&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0242475322&partnerID=8YFLogxK

U2 - 10.1067/S0002-9378(03)01079-2

DO - 10.1067/S0002-9378(03)01079-2

M3 - Article

C2 - 14586318

AN - SCOPUS:0242475322

VL - 189

JO - American Journal of Obstetrics and Gynecology

JF - American Journal of Obstetrics and Gynecology

SN - 0002-9378

IS - 4 SUPPL.

ER -